A research team from the Anhui Institute of Optics and Fine Mechanics, the Hefei Institutes of Physical Science of the ...
Type 1 diabetes is caused by an insufficient production of the hormone insulin by cells in the pancreas called beta cells and ...
D-PLEX₁₀₀ has received Breakthrough Therapy Designation, three QIDP designations, and three Fast Track designations from the U.S. Food and Drug Administration. NDA submission is expected early 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback